Chemo brain under the microscope: largest study yet launched
NCT ID NCT01382082
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks over 1,400 breast cancer and lymphoma patients to see how chemotherapy affects memory, attention, and thinking skills. Researchers test patients before, right after, and up to years after treatment. The goal is to learn who is most at risk for 'chemo brain' and why, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aurora NCORP
Milwaukee, Wisconsin, 53226, United States
-
CCOP - Nevada Cancer Research Foundation
Las Vegas, Nevada, 89106, United States
-
CRCWM
Grand Rapids, Michigan, 49503, United States
-
Cancer Research Consortium of West Michigan
Grand Rapids, Michigan, 49503, United States
-
Columbus
Columbus, Ohio, 43215, United States
-
Columbus NCORP
Columbus, Ohio, 43215, United States
-
Dayton
Dayton, Ohio, 45459, United States
-
Dayton Community Oncology Program
Dayton, Ohio, 45420, United States
-
Delaware/Christiana Care NCORP
Newark, Delaware, 19713, United States
-
Delaware/Christiana Care NCORP (CHRISTIANA)
Newark, Delaware, 19718, United States
-
Gulf South MU-NCORP
New Orleans, Louisiana, 70112, United States
-
Heartland
Decatur, Illinois, 62526, United States
-
Hem Onc CNY
East Syracuse, New York, 13057, United States
-
Kansas City
Rochester, New York, 14642, United States
-
Kansas City Clinical Oncology Program
Prairie Village, Kansas, 66208, United States
-
Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, 55416, United States
-
Metro Minnesota NCORP
Minneapolis, Minnesota, 55426, United States
-
NCORP of the Carolinas
Greenville, South Carolina, 29605, United States
-
Nevada
Las Vegas, Nevada, 89106, United States
-
Northwest (Virginia Mason)
Seattle, Washington, 98101, United States
-
Novant Health Cancer Institute - Kernersville
Winston-Salem, North Carolina, 27103, United States
-
PCRC
Portland, Oregon, 97213, United States
-
Pacific Cancer Research Consortium Ncorp
Portland, Oregon, 97213, United States
-
Southeast Clinical Oncology Research Program
Winston-Salem, North Carolina, 27104, United States
-
University of Rochester Cancer Center
Rochester, New York, 14642, United States
-
Upstate Carolina
Spartanburg, South Carolina, 29303, United States
-
Wichita
Wichita, Kansas, 67214, United States
-
Wichita NCORP
Wichita, Kansas, 67214, United States
-
Wisconsin NCORP
Marshfield, Wisconsin, 54449, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Could muscle loss predict blood cancer outcomes?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple